Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Originally discovered in human plasma in the 1970s, GHK-Cu is recognized for its roles in wound healing, collagen synthesis, and tissue repair
It is currently the only compound of its kind that has received FDA approval (under the name Vyleesi) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, further highlighting its importance as a research molecule
All candidates undergo medical screening prior to approval
If tolerated with minimal side effects, increase by 0.05mg every 4-6 weeks based on how your body responds
Oral solid-form research compound formulated for controlled analytical and investigational applications
US$ 25.17
US$ 20.35
US$ 22.34
US$ 27.05
US$ 27.57
